Pancreatic Cancer Research

ResearcherAstellas Pharma Global Development, Inc.No recent work listed

Medical Monitor

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
0
Pancreatic cancer trials
2
Pancreatic cancer grants
0
Collaborators
0
Papers, trials and grants by year

2010: 1 trial · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 trial

Trials 2

  1. A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects… Study director NCT03565445↗
  2. Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer Study director NCT01010945↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.